Abstract
In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.
| Original language | Hungarian |
|---|---|
| Pages (from-to) | 123-130 |
| Number of pages | 8 |
| Journal | Magyar Noorvosok Lapja |
| Volume | 67 |
| Issue number | 3 |
| Publication status | Published - 2004 |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynaecology
Cite this
A "Millió no vizsgálat" és kritikája. / Dancsó, János; Cseh, Imre; Kanizsai, Beáta; Végh, György; Fülöp, V.
In: Magyar Noorvosok Lapja, Vol. 67, No. 3, 2004, p. 123-130.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A "Millió no vizsgálat" és kritikája
AU - Dancsó, János
AU - Cseh, Imre
AU - Kanizsai, Beáta
AU - Végh, György
AU - Fülöp, V.
PY - 2004
Y1 - 2004
N2 - In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.
AB - In the Million Women Study, published in August 2003 participated nearly one million posstmenopausal women. The authors found unusually high breast cancer risk among the estrogen-progesterone hormone treated patients, and small, but significant increases in other hormone treated groups, including tibolone. Following publication of the Million Women Study, the Committee of Safety of Medicines wrote to all doctors in UK, advising them of breast cancer risk associated with HRT. As a results of the warnings, many women have been wrongly advised to stop, or not even start HRT, with subsequent deterioration in their general health and weell-being. It coused concern among health professionals and women about the use of menopausal hormon treatment. We give an extensive response to the article and its critics, highlighting flaws in the design of the study, which now render unsound any firm conclusions drawn from it. There are concerns that the study over-estimated the risk of breast cancer associated with a short exposure to menopausal hormone therapy.
KW - Beast cancer risk
KW - Estrogen-progesterone therapy
KW - Menopausa
UR - http://www.scopus.com/inward/record.url?scp=2542502355&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2542502355&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:2542502355
VL - 67
SP - 123
EP - 130
JO - Magyar Noorvosok Lapja
JF - Magyar Noorvosok Lapja
SN - 0025-021X
IS - 3
ER -